Manufacturer record
I.G. Pharma Ltd: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
2 batches manufactured by I.G. Pharma Ltd (Uttarakhand) were declared Not of Standard Quality between February 2025 and May 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: IGC-0044, Rabeprazole Sodium (Enteric-Coated) & Domperidone (SR) Capsules. (exp Oct 2027). SDTL, Punjab (state lab) found it not of standard quality: The content of Rabeprazole Sodium found to be 16.22mg/Capsule against labelled claim of 20.0mg/Capsule. Listed in the May 2026 alert.
Records by type
2 records linked to I.G. Pharma Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Rabeprazole Sodium (Enteric-Coated) & Domperidone (SR) Capsules. | Batch IGC-0044Mfg Jan 2025 · Exp Oct 2027 | The content of Rabeprazole Sodium found to be 16.22mg/Capsule against labelled claim of 20.0mg/CapsuleLabelling | SDTL, PunjabState lab | May 2026 |
| Paracetamol & Diclofenac Sodium Tablets I.P. (IG Pyrin) | Batch IGN-2602Mfg May 2023 · Exp Apr 2026 | Dissolution of Paracetamol & Diclofenac SodiumDissolution | RDTL GuwahatiCDSCO lab | Feb 2025 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.